Rating
Buy
Price target
$220
Previous
$220
Implied upside
+9%

Stifel analyst Brad Reback reiterated a Buy rating and $220.00 price target on Oracle (NYSE: ORCL).

“While OCI (+92% Y/Y-CC) and total Cloud growth (46% Y/Y-CC) came in-line with expectations, the stock fell ~12% AH as management’s FY27 profitability commentary means GMs likely decline more than previously expected (we are now modeling down ~1000bps Y/Y vs.

700bps previously).

That said, management expects these headwinds to be offset by a YoY OPEX spending, and that Infrastructure GMs should improve in FY28 as revenue ramps into its capacity.

EPS beat by ~$0.03 excluding a 1x net-investment gain, driven by headcount efficiencies. RPO grew $85B Q/Q, as Oracle signed 4 >$8B and $67B of AI infrastructure contracts.

Looking forward, management reiterated FY27 revenue guidance ($90B) with ~115% implied OCI growth and expects $90-95B of capex ($70B net cash given customer prepayments).

Net/net, despite the lower near-term GMs, we believe that accelerating IaaS growth should lead to better EPS growth rates over the coming years.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.